Schwartz is a seasoned executive with more than two decades of experience in a range of finance roles at health tech and financial services organizations. She joins Resmed from Illumina, Inc., where ...

Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...

Resmed (RMD) announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective April 21. In this role, Schwartz will ...

In the assessment of 12-month price targets, analysts unveil insights for ResMed, presenting an average target of $267.0, a ...

Medical device company ResMed (NYSE:RMD) will be announcing earnings results tomorrow after market close. Here’s what to look ...

Piper Sandler lifted their price target on ResMed from $252.00 to $260.00 and gave the company a “neutral” rating in a research note on Friday, January 31st. Finally, KeyCorp upped their price ...

Shares of ResMed Inc. RMD shed 1.16% to $211.49 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 2.24% to 5,275.70 and Dow ...

Piper Sandler increased their target price on ResMed from $252.00 to $260.00 and gave the company a “neutral” rating in a research report on Friday, January 31st. The Goldman Sachs Group ...

Joey Jordison ’s family have shared the drummer’s original design of the Slipknot logo.

In a fun read, VelvetShark attempts to decipher why most AI companies have opted for a logo reminiscent of the human ...

examining analysts' projections for some of the company's key metrics often helps gain a deeper insight. Given this perspective, it's time to examine the average forecasts of specific ResMed ...

RESMED insiders have traded $RMD stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales. Here’s a ...